financetom
Business
financetom
/
Business
/
Regeneron Pharmaceuticals Gets Accelerated Approval From FDA for Multiple Myeloma Treatment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Regeneron Pharmaceuticals Gets Accelerated Approval From FDA for Multiple Myeloma Treatment
Jul 2, 2025 9:13 AM

11:42 AM EDT, 07/02/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Wednesday the US Food and Drug Administration has granted accelerated approval for Lynozyfic, a treatment for adults with hard-to-treat multiple myeloma.

The decision is based on early results from a clinical trial showing a 70% response rate, including 45% of patients who saw their cancer treated, the company said.

Shares of the company were up more than 2% in recent trading.

Price: 549.23, Change: +14.32, Percent Change: +2.68

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Russia-Ukraine war: Are Western powers doing enough to stop Russia? Here's what experts have to say
Russia-Ukraine war: Are Western powers doing enough to stop Russia? Here's what experts have to say
Feb 25, 2022
Ukraine is under siege as Russian troops moved towards the capital city of Kyiv. Multiple explosions were heard in Kyiv as the city braces for a tank attack. US President Joe Biden has termed Russia's invasion as a "brutal assault" and imposed sanctions on 4 of their largest banks, 13 major enterprises and key Russian oligarchs. There has however been no consensus on removing Russia from the SWIFT payment system. So, are the western powers doing enough to stop Russia's offensive? To discuss this CNBC-TV18 spoke to Vinayak Chatterjee of CII; Amit Bhandhari of Gateway House; Naresh Gehi of Gehi's Immigration & International Legal Services and Sudhir Devare, Former Indian Envoy to Ukraine.
What is SWIFT and how does it affect Russia? 
What is SWIFT and how does it affect Russia? 
Feb 26, 2022
The US and other western countries are mulling throwing Russia out of the global financial transactions system, SWIFT. Founded in 1973 to end reliance on the telex system, SWIFT is an important facilitator of international banking.
Explained: How Russia-Ukraine crisis will impact agri-business in India
Explained: How Russia-Ukraine crisis will impact agri-business in India
Feb 25, 2022
Russia’s invasion of Ukraine and subsequent sanctions have spelt chaos for markets, commodities and supply chains globally. While the crisis will hit India hard, it could also boost exports from the country. At present, India's central pool of wheat stands at 24.2 million tonnes, which is twice more than buffer and strategic needs.
BP to exit Russia oil giant Rosneft at cost of $25 billion over Ukraine invasion
BP to exit Russia oil giant Rosneft at cost of $25 billion over Ukraine invasion
Feb 27, 2022
BP has held a 19.75 percent stake in Rosneft since 2013 and company said that its CEO, Bernard Looney, and former BP executive Bob Dudley will immediately resign from Rosneft's board.
Copyright 2023-2026 - www.financetom.com All Rights Reserved